•  
  •  
  •  
  •  

2026-07-19 17:49:52

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • LTM Partners with Glean to Accelerate Enterprise AI Adoption
  • Rajesh Power Services Ltd receives orders from PGVCL
  • Muthoot Capital Services Q1 FY27 Results: Net Profit Surges 51.4% Sequentially to ₹812.21 Lakhs, Turning Profitable Year-on-Year
  • PNB Gilts Q1 FY27 Results: Net Profit Surges Over 500% Sequentially to ₹8,069.80 Lakhs, Driven by Strong Operating Performance
  • WeWork India Management Limited Q1 FY27 Results: Revenue Rises 27.7% YoY to ₹6,838.32 Million; Narrower Losses Driven by High Lease/Finance Overheads

Keywords Selected:  USFDA

Stock Report

  • Ajanta Pharma Ltd receives EIR from USFDA for Paithan facility
  • Lupin Receives EIR from U.S. FDA for its Somerset Facility with VAI Classification
  • US FDA inspection at Glenmark Pharmaceuticals Ltd's manufacturing facility in Goa, India
  • Completion of US FDA Inspection at Auroactive Pharma Pvt Ltd
  • Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapsone Gel, 5%
  • Lupin receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
  • Completion of US FDA Pre-Approval Inspection at Eugia Steriles Private Limited
  • Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
  • Classification of US FDA Inspection at Unit-III of Eugia Pharma Specialities Ltd, Pashamylaram as OAI
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.05%
  • USFDA inspection at Cipla Ltd's manufacturing facility in Verna, Goa, India
  • Alembic Pharmaceuticals Ltd announces USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg
  • Concord Biotech Ltd receives ANDA approval for Tofacitinib Tablets, 5 mg and 10 mg
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg
  • Lupin receives approval from U.S. FDA for Ranluspec™ (ranibizumab) Injection
  • Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
  • NATCO and Lupin receive approval from U.S. FDA for Eribulin Mesylate Injection
  • Concord Biotech Ltd receives ANDA approval from USFDA for Mycophenolate Mofetil for Oral Suspension USP
  • Zydus Therapeutics receives USFDA priority review to NDA for Saroglitazar
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Levothyroxine Sodium Tablets USP
  • Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
  • US FDA Inspection at Alkem Laboratories Ltd's CRO facility located at Taloja
  • USFDA inspection concludes at Zydus' Biologics Injectable plant, Ahmedabad
  • Caplin Steriles Ltd gets USFDA approval for Calcium Gluconate Injection

Latest Post

  • LTM Partners with Glean to Accelerate Enterprise AI Adoption
  • Rajesh Power Services Ltd receives orders from PGVCL
  • Muthoot Capital Services Q1 FY27 Results: Net Profit Surges 51.4% Sequentially to ₹812.21 Lakhs, Turning Profitable Year-on-Year
  • PNB Gilts Q1 FY27 Results: Net Profit Surges Over 500% Sequentially to ₹8,069.80 Lakhs, Driven by Strong Operating Performance
  • WeWork India Management Limited Q1 FY27 Results: Revenue Rises 27.7% YoY to ₹6,838.32 Million; Narrower Losses Driven by High Lease/Finance Overheads


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025